Cytosorbents Crp
NASDAQCM:CTSO
United States / Healthcare / Healthcare Equipment & Supplies
Exchange Data
Hide this widget
Price
1.00 USD
Day change
0.00 (0.00%)
52-week range
0.70 - 1.61
19:59 - Closed
After Hours1.04 +0.04 (+4.00%)
Summary of Cytosorbents Crp
Hide this widget
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platfor...
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
- (-)
Data Explorer
Hide this widget
Data could not be retrieved
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| CTSO | Peers | Sector | |
|---|---|---|---|
Market Cap | 54.68 M | 130.9 M | 64.213 M |
Price % of 52 Week High | Premium | 63.3% | 62.0% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | Premium | -1.7% | -0.7% |
1 Year Price Total Return | 5.3% | -20.8% | -12.0% |
Beta (5 Year) | 0.78 | 1.54 | 0.64 |
In the News
Hide this widget
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for Cytosorbents Crp is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Financial Models for Cytosorbents Crp
Model Gallery
Hide this widget
| 5Y DCF EBITDA ExitView Updated 20 hours ago |
| 5Y DCF Revenue ExitView Updated 20 hours ago |
| DuPont ROE AnalysisView Updated 11 hours ago |
| Earnings Power ValueView Updated 20 hours ago |
| 10Y Historical FinancialsView Updated 11 hours ago |
| 5Y Historical FinancialsView Updated 11 hours ago |
| EV / EBIT MultiplesView Updated 20 hours ago |
| EV / EBITDA MultiplesView Updated 20 hours ago |
| P/E MultiplesView Updated 20 hours ago |
| Price / Book MultiplesView Updated 20 hours ago |
| Price / Sales MultiplesView Updated 20 hours ago |
| EV / Revenue MultiplesView Updated 20 hours ago |
| CAPM WACC ModelView Updated 14 hours ago |
| 10Y DCF EBITDA ExitView Updated 20 hours ago |
| 10Y DCF Revenue ExitView Updated 20 hours ago |
| 10Y DCF Growth ExitView Updated 20 hours ago |
| 5Y DCF Growth ExitView Updated 20 hours ago |
Historical Financials
Full Financials
Hide this widget
| (USD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Sept-24 | Sept-23 | Sept-24 |
| Income Statement | |||||
| Revenue | 35 | 36 | 38 | 8.81 | 9.39 |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | |||||
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 18 | 18 | 27 | 18 | 27 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | (34) | (22) | (19) | (5.35) | (2.61) |
Analyst Notes
March 29, 2025
Hide this widget